Keywords: dxs, develop, v600e, b-raf, mutation, uk-based, personalized

DxS to develop V600E B-RAF mutation test

Article | 08 September 2008

Print This

DxS, a UK-based personalized medicine company, has signed a non-exclusive global licensing agreement with the Wellcome Trust to provide a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in